Thrombolysis with recombinant tissue plasminogen activator in atherosclerotic thrombotic occlusion
- 1 January 1985
- journal article
- research article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 5 (1) , 85-91
- https://doi.org/10.1016/s0735-1097(85)80088-7
Abstract
No abstract availableThis publication has 26 references indexed in Scilit:
- Coronary Thrombolysis with Tissue-Type Plasminogen Activator in Patients with Evolving Myocardial InfarctionNew England Journal of Medicine, 1984
- Coronary thrombolysis with intravenously administered human tissue-type plasminogen activator produced by recombinant DNA technology.Circulation, 1984
- Western Washington Randomized Trial of Intracoronary Streptokinase in Acute Myocardial InfarctionNew England Journal of Medicine, 1983
- Systemic thrombolytic therapy of acute myocardial infarction?Circulation, 1983
- Clot-Selective Coronary Thrombolysis with Tissue-Type Plasminogen ActivatorScience, 1983
- A Randomized Trial of Intracoronary Streptokinase in the Treatment of Acute Myocardial InfarctionNew England Journal of Medicine, 1983
- Thrombolysis with Human Extrinsic (Tissue-Type) Plasminogen Activator in Rabbits with Experimental Jugular Vein Thrombosis. EFFECT OF MOLECULAR FORM AND DOSE OF ACTIVATOR, AGE OF THE THROMBUS, AND ROUTE OF ADMINISTRATIONJournal of Clinical Investigation, 1983
- Thrombolysis in acute myocardial infarction: treatment of the underlying coronary artery disease.Circulation, 1982
- Changes in left ventricular function after intracoronary streptokinase infusion in clinically evolving myocardial infarctionAmerican Heart Journal, 1981
- Non surgical coronary artery recanalization in acute transmural myocardial infarction.Circulation, 1981